tiprankstipranks
Trending News
More News >
Advertisement

Biotech & Longevity Plays

GLP-1 & gene therapies target oncology/longevity; LLY & NOVO lead with 45%+ YTD on M&A and epigenetic resets.

Comparison Results

Name
Price
Volume
Analyst Price Target
Analyst Consensus
Smart Score
Market Cap
P/E Ratio
Dividend Yield
Sector
Article
Follow
LLY$1079.751.25M
xxxxxxxxxxxxx
18 Buy
2 Hold
0 Sell
Strong Buy
$1.02T53.350.56%Healthcare
NVO$51.2211.90M
xxxxxxxxxxxxx
4 Buy
4 Hold
1 Sell
Moderate Buy
$228.73B14.973.59%Healthcare
ARQT$28.081.39M
xxxxxxxxxxxxx
7 Buy
1 Hold
0 Sell
Strong Buy
$3.50BHealthcare
EXAS$101.90837.93K
xxxxxxxxxxxxx
3 Buy
17 Hold
0 Sell
Hold
$19.34BHealthcare
TNGX$8.634.90M
xxxxxxxxxxxxx
6 Buy
1 Hold
0 Sell
Strong Buy
$1.18BHealthcare
INSM$174.091.65M
xxxxxxxxxxxxx
16 Buy
1 Hold
0 Sell
Strong Buy
$37.61BHealthcare

Performance Comparison

Ticker
Company Name
Price
Change
% Change
LLY
Eli Lilly & Co
1,079.75
313.47
40.91%
NVO
Novo Nordisk
51.22
-33.12
-39.27%
ARQT
Arcutis Biotherapeutics
28.08
14.15
101.58%
EXAS
Exact Sciences
101.90
45.71
81.35%
TNGX
Tango Therapeutics
8.63
5.54
179.29%
INSM
Insmed
174.09
105.05
152.16%

Biotech & Longevity Plays Latest News

Read the latest stock news and analysis from the TipRanks news team.

Recent Analysts Ratings of Biotech & Longevity Plays Stocks

Name
Analyst
Analyst Firm
Rating
Price Target
Upside / Downside
Action
Date
Eli Lilly & Co
Buy
Reiterated
Arcutis Biotherapeutics
Buy
Reiterated
Tango Therapeutics
Buy
Initiated
Exact Sciences
Hold
Downgraded
Arcutis Biotherapeutics
Buy
Reiterated
Eli Lilly & Co
Buy
Reiterated
Eli Lilly & Co
Buy
Reiterated

Most Recent Earnings of Biotech & Longevity Plays Stocks

Name
Report Date
Time Of Day
Period Ending
Forecast / EPS
Last Year's EPS
Eli Lilly & Co
Oct 30, 2025
Dec 01, 2025
7.16 / 20.22
5.32
Novo Nordisk
Nov 05, 2025
Dec 01, 2025
0.92 / 3.44
0.886
Arcutis Biotherapeutics
Oct 01, 2025
Dec 01, 2025
0.07 / -0.35
-0.09
Exact Sciences
Nov 03, 2025
Dec 01, 2025
-0.08 / -5.32
-4.67
Tango Therapeutics
Nov 04, 2025
Dec 01, 2025
-0.32 / -0.92
-0.35
Insmed
Oct 30, 2025
Dec 01, 2025
-1.28 / -6.18
-1.32

Biotech & Longevity Plays - FAQ

Which Biotech & Longevity Plays stocks have a "Strong Buy" analyst rating?
These Biotech & Longevity Plays stocks currently have a "Strong Buy" analyst rating consensus:
Eli Lilly & Co - Strong Buy, based on 20 analyst ratings, 18 Buy, 2 Hold, and 0 Sell.
    Arcutis Biotherapeutics - Strong Buy, based on 8 analyst ratings, 7 Buy, 1 Hold, and 0 Sell.
      Tango Therapeutics - Strong Buy, based on 7 analyst ratings, 6 Buy, 1 Hold, and 0 Sell.
        Insmed - Strong Buy, based on 17 analyst ratings, 16 Buy, 1 Hold, and 0 Sell.
          Are Biotech & Longevity Plays stocks overpriced?
          Eli Lilly & Co's stock price is currently $1,079.75, and its average 12-month price target is $1,152.00.
            Novo Nordisk's stock price is currently $51.22, and its average 12-month price target is $55.30.
              Arcutis Biotherapeutics's stock price is currently $28.08, and its average 12-month price target is $30.25.
                Exact Sciences's stock price is currently $101.90, and its average 12-month price target is $98.94.
                  Tango Therapeutics's stock price is currently $8.63, and its average 12-month price target is $13.67.
                    Insmed's stock price is currently $174.09, and its average 12-month price target is $219.00.
                      Which Biotech & Longevity Plays stocks pay dividends?
                      Eli Lilly & Co currently pays a dividend of $1.73 which represents an annual dividend yield of 0.56%. Eli Lilly & Co's next Ex-dividend date is February 13, 2026 and its next payout date is March 10, 2026.
                        Novo Nordisk does not currently pay dividends.
                          Arcutis Biotherapeutics does not currently pay dividends.
                            Exact Sciences does not currently pay dividends.
                              Tango Therapeutics does not currently pay dividends.
                                Insmed does not currently pay dividends.

                                  Latest News​

                                  Sirisha Bhogaraju

                                  Top 5 Trending Stocks by Unusual Trading Volume, 12/31/25

                                  Kirti Tak

                                  NKE Insider Trade Alert! Nike Stock Pops After CEO Elliott Hill Buys $1M in Shares

                                  Kirti Tak

                                  Nvidia (NVDA) Ends Year Strong With $14B AI Chip Boost From ByteDance

                                  Shalu Saraf

                                  Apple’s ‘Invisible AI’ Strategy Is Why 5-Star Analyst Dan Ives Sees Upside Into 2026

                                  Michael Marcus

                                  2 New IPO Stocks Enter the Fray; J.P. Morgan Says ‘Buy’

                                  Shalu Saraf

                                  Cathie Wood Closes Out 2025 with a Rocket Lab (RKLB) Trim and Fresh Biotech Bets

                                  Shalu Saraf

                                  BABA vs. AMZN: Which ‘Strong Buy’ E-Commerce Stock Offers More Upside Into 2026?

                                  Vince Condarcuri

                                  IBM Is Still Undervalued, According to Jim Cramer

                                  Shalu Saraf

                                  U.S. Stock Futures Edge Lower Ahead of Last Day of 2025

                                  Shalu Saraf

                                  Is Tilray Brands (TLRY) a Buy Ahead of Q2 Earnings?

                                  Shalu Saraf

                                  ‘We Want to Own It,’ Says Top Analyst About Tesla Stock (TSLA)

                                  Michael Byrne

                                  Price and Dividend Combo Make Altria Stock (MO) a Worthy Contender in 2026

                                  Vince Condarcuri

                                  Expert Warns that AI’s ‘Circular Financing’ Could Inflate Market Risk in 2026

                                  Eddie Pan

                                  Stock Market News Review: SPY, QQQ Tick Lower as Fed Minutes Suppress Rate Cut Odds

                                  Vince Condarcuri

                                  These Restaurant Brands Were Forced to Close Stores in 2025

                                  Biotech & Longevity Plays Stock Events

                                  Stock
                                  Type
                                  Date
                                  Novo Nordisk
                                  Earnings Release
                                  Feb 04, 2026
                                  Eli Lilly & Co
                                  Earnings Release
                                  Feb 11, 2026
                                  Eli Lilly & Co
                                  Ex-Dividend Date
                                  Feb 13, 2026
                                  Insmed
                                  Earnings Release
                                  Feb 19, 2026
                                  Exact Sciences
                                  Earnings Release
                                  Feb 24, 2026

                                  Popular Stocks

                                  Company
                                  Price & Change
                                  Follow
                                  Nvidia
                                  Apple
                                  Microsoft